Insulin glargine and its two active metabolites: A sensitive (16Â pM) and robust simultaneous hybrid assay coupling immunoaffinity purification with LC-MS/MS to support biosimilar clinical studies
Keywords: تصفیه ایمنی آلاینده; IAP; immunoaffinity purification; SPE; solid-phase extraction; Insulin glargine and its active metabolites M1 and M2; Immunoaffinity purification (IAP); LC-MS/MS; Hybrid method; Biosimilar clinical studies;